E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/17/2009 in the Prospect News Investment Grade Daily.

Fitch gives Pfizer notes AA

Fitch Ratings said it has assigned an AA rating to Pfizer Inc.'s proposed public issuance of $13.5 billion of senior unsecured notes, comprising five tranches.

The debt offering comprises two-year floating-rate notes, three-year fixed-rate notes, six-year fixed-rate notes, 10-year fixed-rate notes and 30-year fixed-rate notes, the agency said.

Proceeds from the senior unsecured debt are expected to be used for general corporate purposes and to partially finance the acquisition of Wyeth, the agency noted.

Fitch said it has also placed Pfizer's new notes on rating watch negative, along with the company's other outstanding debt: long-term issuer default rating AA; senior unsecured debt AA; bank loan AA; short-term issuer default rating F1+; and commercial paper F1+.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.